EUVIMEDEUVIMED entdecken
Kohortenstudie

Plasma Levels of Chitinase 3‐Like 1 Protein Increase in Patients With Neurodegenerative Diseases: A Small Cohort Study

Ebru Haciosmanoglu Aldogan, Birsen Elibol iD, Nur Damla Korkmaz, Zehra Cemre Karakayali, Gulsen Babacan Yildiz

Geriatrics & Gerontology International · 2025

DOI: 10.1111/ggi.70253 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Geriatrics & Gerontology International, 2025. Verfasst von Ebru Haciosmanoglu Aldogan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Alzheimer Disease, Parkinson Disease, Neurodegenerative Diseases. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neuroinflammation, widely regarded as a chronic inflammatory response of the central nervous system, is thought to be a key player in the initiation of neurodegeneration. While there is a great effort in finding useful biomarkers for early detection of neurodegenerative diseases such as Alzheimer's disease (AD) or Parkinson's disease (PD), a precise biomarker capable of elucidating the disease progression and effectiveness of therapeutic interventions is needed.

Methods

The plasma NLRP3, ASC, IL‐1β, IL‐6, IL‐10, and CHI3L1 levels were measured in control subjects and patients with AD and PD by ELISA to evaluate whether these molecules can be biomarkers with a high diagnostic power.

Results

While there is no significant difference in the levels of NLRP3, ASC, IL‐1β, and IL‐10, CHI3L1 was significantly elevated in the AD and PD patients compared to the healthy controls. In addition, in AD patients, IL‐6 levels significantly increased and there was a positive correlation between IL‐6 and CHI3L1 levels. In the PD patients, there was a negative correlation between IL‐6 and CHI3L1. According to the ROC curves, the levels of CHI3L1 had better sensitivity and specificity than other parameters to distinguish AD and PD.

Conclusion

In summary, our results indicated that plasma CHI3L1 level can be useful as one of the biomarkers in AD and PD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chitinase-3-Like Protein 1Alzheimer DiseaseParkinson DiseaseNeurodegenerative DiseasesHumansFemaleMaleBiomarkersAgedEnzyme-Linked Immunosorbent AssayMiddle AgedCohort StudiesCase-Control StudiesROC Curve

Stichwörter der Autor:innen

Alzheimer's diseaseParkinson diseasechitinase 3‐like 1 proteinhuman blood plasmaneuroinflammation

Substanzen

Chitinase-3-Like Protein 1BiomarkersCHI3L1 protein, human

Autor:innen und Institutionen

  • Department of Biophysics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Department of Neurology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Department of Neurology, Istanbul Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Birsen Elibol

Zitieren

APA

Haciosmanoglu Aldogan, E., Elibol, B., Korkmaz, N. D., Karakayali, Z. C., & Yildiz, G. B. (2025). Plasma Levels of Chitinase 3‐Like 1 Protein Increase in Patients With Neurodegenerative Diseases: A Small Cohort Study. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.70253

Vancouver

Haciosmanoglu Aldogan E, Elibol B, Korkmaz ND, Karakayali ZC, Yildiz GB. Plasma Levels of Chitinase 3‐Like 1 Protein Increase in Patients With Neurodegenerative Diseases: A Small Cohort Study. Geriatrics & Gerontology International. 2025. doi:10.1111/ggi.70253

BibTeX
@article{HaciosmanogluAldogan2025,
  author = {Haciosmanoglu Aldogan, Ebru and Elibol, Birsen and Korkmaz, Nur Damla and Karakayali, Zehra Cemre and Yildiz, Gulsen Babacan},
  title = {Plasma Levels of Chitinase 3‐Like 1 Protein Increase in Patients With Neurodegenerative Diseases: A Small Cohort Study},
  journal = {Geriatrics & Gerontology International},
  year = {2025},
  doi = {10.1111/ggi.70253}
}
Kostenlos starten →